Khanban, H., Fattahi, E., & Talkhabi, M. (2019). In vivo administration of G9a inhibitor A366 decreases osteogenic potential of bone marrow-derived mesenchymal stem cells. EXCLI Journal, 18, 300–309. https://doi.org/10.17179/excli2019-1234